Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart
Cardiovascular Research · 28.08.2025 · 121 (10) · 1594-1608
DOI: 10.1093/cvr/cvaf046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 21.03.2025. Verfasst von Nivethitha Manickam und 19 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Molecular Medicine, Institute of Cardiovascular Regeneration, Goethe University Frankfurt, Theodor Stern Kai 7, Building 25B, Frankfurt 60…. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor B, Aging, Genetic Therapy, Myocardium. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, German Research Foundation, Cluster of Excellence Cardiopulmonary Institute.
Abstract (Originalsprache)
Aims
Members of the VEGF family are crucial modulators of vascular and neural function. While VEGFA signalling has been shown to mitigate several aging-related cardiac phenotypes and prolong survival in aged mice, the role of VEGFB in cardiac aging remains underexplored. In this study, we identify a significant decline in Vegfb expression, particularly of its soluble isoform Vegfb186, in aged mouse and human hearts. To assess the therapeutic potential of VEGFB in aging-associated cardiac pathologies, we used AAV9-mediated gene transfer to overexpress Vegfb186 in 18-month-old male C57Bl/6J mice. Methods and results VEGFB is known to exhibit vascular and neuroprotective effects that we assessed in the ageing heart. In the aged heart, doses of Vegfb186 overexpression that had only a modest effect on the vascular endothelium prevented age-induced diastolic dysfunction and fibrosis. Vegfb186 treatment additionally restored sympathetic and sensory nerve fibre density and increased heart rate variability. Although Vegfb186 overexpression induced cardiac hypertrophy, our findings indicated that this hypertrophy was compensatory rather than pathological as Vegfb186 overexpression corrected the elevated cardiomyocyte length-to-width ratio observed in aged hearts, a metric typically indicative of pathological remodelling. Cardiac single-nucleus RNA sequencing of the hearts and in vitro analysis of the cardiomyocytes indicated up-regulation of the STAT3 signal transduction pathway as a potential contributor of VEGFB-induced cardiac hypertrophy.
Conclusion
Our findings demonstrate that Vegfb186 overexpression partially reverses age-related cardiac pathologies such as diastolic dysfunction and fibrosis. This work highlights VEGFB as a potential therapeutic target for combating cardiac aging and its associated dysfunctions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Molecular Medicine, Institute of Cardiovascular Regeneration, Goethe University Frankfurt, Theodor Stern Kai 7, Building 25B, Frankfurt 60590, Germany.
- Translational Cancer Medicine Program, University of Helsinki, Helsinki 00290, Finland.
- Wihuri Research Institute, Biomedicum Helsinki, Helsinki 00290, Finland.
- German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Frankfurt 60590, Germany.
- Cardiopulmonary Institute (CPI), Frankfurt 60590, Germany.
- Centre for Molecular Medicine, Institute for Cardiovascular Physiology, Goethe University Frankfurt, Frankfurt 60590, Germany.
ORCID-Profile: David John, Thomas Braun, Kari Alitalo, Stefanie Dimmeler, Julian U G Wagner
Förderung
- European Research Council
- German Research Foundation
- Cluster of Excellence Cardiopulmonary Institute
- DZHK
- German Centre for Cardiovascular Research
- RheinMain
- Frankfurt am Main
- Dr. Rolf-M.-Schwiete Foundation
Zitieren
APA
Manickam, N., Sultan, I., Panthel, J., Kujundzic, H., Fischer, A., Schmitz, K., Ruz Jurado, M., Rodriguez Morales, D., John, D., Glaser, S. F., Stilz, K. A., Malacarne, P. F., Brandes, R. P., Braun, T., Lerchenmüller, C., Betge, F., Abplanalp, W. T., Alitalo, K., Dimmeler, S., & Wagner, J. U. G. (2025). Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart. Cardiovascular Research, 121(10), 1594-1608. https://doi.org/10.1093/cvr/cvaf046
Vancouver
Manickam N, Sultan I, Panthel J, Kujundzic H, Fischer A, Schmitz K, et al. Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart. Cardiovascular Research. 2025;121(10):1594-1608. doi:10.1093/cvr/cvaf046
BibTeX
@article{Manickam2025,
author = {Manickam, Nivethitha and Sultan, Ibrahim and Panthel, Josefine and Kujundzic, Haris and Fischer, Ariane and Schmitz, Katja and Ruz Jurado, Mariano and Rodriguez Morales, David and John, David and Glaser, Simone-Franziska and Stilz, Kathrin A and Malacarne, Pedro Felipe and Brandes, Ralf Peter and Braun, Thomas and Lerchenmüller, Carolin and Betge, Fynn and Abplanalp, Wesley T and Alitalo, Kari and Dimmeler, Stefanie and Wagner, Julian U G},
title = {Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart},
journal = {Cardiovascular Research},
year = {2025},
volume = {121},
number = {10},
pages = {1594--1608},
doi = {10.1093/cvr/cvaf046}
}
EUVIMED